Related Experiment Video
Updated: Jan 11, 2026

In Vitro Modeling of Cancerous Neural Invasion: The Dorsal Root Ganglion Model
Published on: April 12, 2016
LRP1 regulates GDNF secretion and perineural invasion in pancreatic cancer via PI3K/AKT signaling
Songmei Lou1, Shenhao Liu2, Mengying Zhu3
1Department of General Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310016, PR China.
Abstract:
Pancreatic cancer induces intense abdominal pain through the infiltration of cancer cells into surrounding nerve tissues, leading to sensory neuron damage. The research aims to identify pivotal molecules involved in PNI, contributing to clinical strategies that alleviate pain and enhance the quality of life for patients. This study used shRNA interference lentivirus to downregulate LRP1 expression in pancreatic cancer and neural cells, comparing perineural invasion (PNI) and neurotrophic factor level changes. An in vitro co-culture model of pancreatic cancer cells with dorsal root ganglia (DRG) assessed the impact of reduced LRP1 on DRG synaptic growth. Additionally, an animal model of neural invasion studied the effects of LRP1 downregulation on neural function. The mutual attraction between Panc-1 and SK-N-SH cells was suppressed upon the downregulation of LRP1 levels in both cell lines. Subsequent investigations revealed a reduction in the autocrine and paracrine secretion of neurotrophic factors and their receptors between Panc-1 and SK-N-SH with the decrease in LRP1 levels. At the tissue level, a significant inhibition of DRG growth was observed. The reduction of LRP1 expression effectively inhibits pancreatic cancer PNI. Concurrently, levels of neurotrophic factors and their receptors in the tumor-neural microenvironment decrease. Mechanistically, LRP1 knockdown suppressed PI3K/AKT and ERK signaling pathways, leading to reduced GDNF secretion and impaired perineural invasion. LRP1 may act as an important molecule in modulating communication between pancreatic cancer cells and neural tissues. Our study offers new potential targets for the treatment of pancreatic cancer neural invasion.
Insights
Reducing LRP1 in pancreatic cancer cells inhibits perineural invasion (PNI) and nerve growth. This discovery offers new therapeutic targets for managing pancreatic cancer pain and neural invasion.
Area of Science:
- Oncology
- Neuroscience
- Molecular Biology
Background:
- Pancreatic cancer causes severe pain via cancer cell infiltration into nerves, known as perineural invasion (PNI).
- Understanding the molecular mechanisms driving PNI is crucial for developing effective pain management strategies.
- Identifying key molecules involved in PNI can lead to novel therapeutic targets.
Purpose of the Study:
- To investigate the role of LRP1 (Low-density lipoprotein receptor-related protein 1) in pancreatic cancer perineural invasion.
- To determine the impact of LRP1 downregulation on the communication between pancreatic cancer cells and neural tissues.
- To explore LRP1 as a potential therapeutic target for pancreatic cancer-associated pain and neural invasion.
Main Methods:
- Utilized shRNA lentivirus to downregulate LRP1 expression in pancreatic cancer (Panc-1) and neural (SK-N-SH) cells.
- Employed an in vitro co-culture model of pancreatic cancer cells with dorsal root ganglia (DRG) to assess synaptic growth.
- Investigated PNI and neurotrophic factor levels in an animal model of neural invasion.
Main Results:
- Downregulation of LRP1 suppressed the mutual attraction between pancreatic cancer and neural cells.
- Reduced LRP1 levels decreased autocrine and paracrine secretion of neurotrophic factors and their receptors.
- Inhibition of LRP1 significantly reduced DRG growth and perineural invasion, impacting PI3K/AKT and ERK signaling pathways.
Conclusions:
- LRP1 plays a critical role in mediating the communication between pancreatic cancer cells and surrounding neural tissues.
- LRP1 downregulation effectively inhibits pancreatic cancer perineural invasion and associated neurotrophic factor signaling.
- Targeting LRP1 presents a promising therapeutic strategy for pancreatic cancer neural invasion and pain management.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:

